CYBB and metabolic dysfunction-associated steatohepatitis: Likewise, no significant changes were observed regarding Nox2, although a ten times higher dose of sitagliptin has been shown to downregulate its expression in the fibrotic livers of mice with nonalcoholic steatohepatitis [40].